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Edited by Vladimir SkulachevAbstract Human Tid-1 (hTid-1) is a DnaJ chaperone protein
with homology to the Drosophila tumor suppressor Tid56. We
report the ﬁrst case of a tumor-associated mutation at the human
TID1 locus, which was identiﬁed in the SF767 glioma cell line
giving rise to aberrantly high levels of a hTid-1L mutant variant.
In this study, we set out to determine whether this change in
hTid-1 status inﬂuences the response of glioma cells to adenovi-
ral (Ad)-mediated delivery of the two major isoforms of TID1,
hTid-1L and hTid-1S. Ad-hTid-1S induced apoptosis in hTid-1
mutant SF767 cells, while causing growth arrest in wild-type
hTid-1-expressing U373 and U87 cells. By contrast, Ad-hTid-
1L infection had no apparent eﬀect on glioma cell growth. The
apoptosis induced by hTid-1S was accompanied by mitochondrial
cytochrome C release and caspase activation and blocked by sta-
ble overexpression of Bcl-XL. Our ﬁndings suggest that the sta-
tus of hTid-1 in gliomas may contribute to their susceptibility to
cell death triggers.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Human Tid-1 (hTid-1), the human homolog of the Dro-
sophila Tid56 tumor suppressor protein, is a member of the
DnaJ family of co-chaperones [1,2]. Three alternatively
spliced variants of the human TID1 gene have been described
[3], the hTid-1L and hTid-1S being the most abundant [3–5].
Expression of the third and shortest splice variant is restricted
to the thymus [3], and the corresponding endogenous 38-kDa
protein has only been detected in cell lysates from human
Thp1 and U937 leukemia lines [6]. Previous studies haveAbbreviations: Ci, cubitis interruptus; CMV, cytomegalovirus; FBS,
fetal bovine serum; GFP, green ﬂuorescent protein; Hh-Ptc, Hedge-
hog-Patched; hTid-1, human Tid-1; LOH, loss of heterozygosity;
MOI, multiplicity of infection; MMP, mitochondrial membrane per-
meability; PARP, poly(ADP-ribose) polymerase; PBS, phosphate-bu-
ﬀered saline; PCR, polymerase chain reaction; PI, propidium iodide;
PT, permeability transition; Rb, retinoblastoma; RT, reverse trans-
criptase; TID, tumorous imaginal discs; VHL, von Hippel-Lindau
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doi:10.1016/j.febslet.2004.11.034demonstrated that DnaJ proteins function as essential regula-
tory cofactors to the heat shock 70 (Hsp70) family of molec-
ular chaperones [2] and cooperate in various cellular
processes, including intracellular protein folding, traﬃcking
and degradation [7,8]. More recently they have emerged as
integral components of signal transduction pathways, in
which they function in the assembly, activation or inactiva-
tion of multiple key signaling molecules that regulate cell cy-
cle progression and apoptosis and which ﬁgure prominently
in human cancers. These include the p53 [9,10], retinoblas-
toma (Rb) [11,12], von Hippel-Lindau (VHL) [13,14] and
Wilms (WT1) [15] tumor suppressors, p27KIP1 [16], Raf-1 ki-
nase [12,17] and Apaf-1 [18,19].
Drosophila Tid56 is the ﬁrst member of the DnaJ co-chaper-
one family to be classiﬁed as tumor suppressor [20]. Recently,
genetic studies in Drosophila have implicated l(2)tid as a novel
component of the Hedgehog-Patched (Hh-Ptc) signaling path-
way, which directs embryonic development and transcriptional
regulation of genes such as wingless (wng) and Cubitus inter-
ruptus (Ci) that control cell proliferation and cell-fate speciﬁca-
tion [21]. Disruption of this pathway in humans through
mutational inactivation of Ptc or ampliﬁcation of Gli, the hu-
man homolog of Ci, predisposes individuals to medulloblas-
toma [22] and glioblastoma [23], underscoring the potential
physiological signiﬁcance of human Tid-1 in tumor progres-
sion processes in the brain.
Loss of heterozygosity (LOH) within the chromosomal re-
gion of 16p13.3 to which the human TID1 gene has been
mapped is associated with a number of human malignancies,
including tumors of glial origin [24,25]. Ours is the ﬁrst study
to identify a coding region sequence mutation targeting a
member of the chaperone family. We found one glioma cell
line, SF767, with a heterozygous TID1 frameshift mutation
which yields aberrantly high levels of a 52-kDa hTid-1L mu-
tant variant. Moreover, we demonstrate that the hTid-1S iso-
form can readily stimulate a Bcl-XL-sensitive cell death
program in gliomas harboring a mutant hTid-1 but not in cells
proﬁcient in hTid-1. Our results suggest that the status of
hTid-1 in gliomas may contribute to cellular susceptibility to
apoptotic triggers.2. Materials and methods
2.1. Cell lines
The human glioma cell lines U87, U373, SF767, SF126 and SF188
were obtained from the University of California at San Francisco
Brain Research Center. 293/293T cells and COS-1 were purchasedblished by Elsevier B.V. All rights reserved.
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gles medium supplemented with 10% fetal bovine serum (FBS) at 37
C and 5% CO2.
2.2. Cloning and recombinant expression of hTid-1L mutant
Total RNA was isolated from cultured SF767 cells using RNeasy
Kit (Qiagen) and was reverse transcribed to cDNA using Superscript
II Reverse Transcriptase (Invitrogen) and oligo(dT) primers, each
according to the manufacturers instructions. Several overlapping
PCRs were then performed using Expand High Fidelity Taq DNA
polymerase (Roche) that spanned the entire human TID1 cDNA. Poly-
merase chain reaction (PCR) products were gel puriﬁed by using the
QIAEXII DNA extraction kit (Qiagen) for direct sequencing. cDNA
encoding the mutant hTid-1L identiﬁed in SF767 cells was subcloned
into pCDNA3 (Invitrogen). Transient transfections were performed
by calcium phosphate-DNA precipitation.
2.3. Construction and preparation of recombinant adenoviruses
The cDNAs encoding full-length hTid-1L (amino acid residues 1–
480) and hTid-1S (amino acid residues 1–453) were cloned downstream
of the cytomegalovirus (CMV) immediate early promoter of the aden-
oviral shuttle vector pAdTrack-CMV [26]. HPD mutants of hTid-1L
and hTid-1S were constructed by site-directed mutagenesis using syn-
thetic oligonucleotides to generate a PCR fragment incorporating a
H121Q base substitution of the HPD motif within the J-domain of
hTid-1. Recombinant adenoviral stocks were generated and puriﬁed
as previously described [26]. Glioma cells were infected with a multi-
plicity of infection (MOI) between 150 and 300.
2.4. Generation of SF767 stable cell lines
High titer retrovirus was generated by transfection of a retrovirus
packaging line 293T, with pBabe or pBabe/Bcl-XL as described previ-
ously [27]. SF767 cells were incubated with retrovirus for 1 h at 37 C,
additional medium was then added and cells were cultured for 48 h be-
fore beginning selection of infected cells in medium containing puro-
mycin (1 lg /ml).
2.5. Immunoblot analysis
Cells were washed twice with PBS and lysed in 2· SDS sample buf-
fer. For Western blot analysis of PARP cleavage, cells were lysed in
SDS reducing buﬀer (62 mM Tris–HCl, pH 6.8, 6 M urea, 10% glyc-
erol, 2% SDS, and 0.0025% bromophenol blue), sonicated for 20 s, fol-
lowed by 30 min incubation at 37 C. Protein concentrations were
determined using the Bio-Rad protein assay. A total of 50 lg of pro-
tein from each sample was then separated by SDS–PAGE and trans-
ferred to a polyvinylidene diﬂuoride membrane and subjected to
Western blot analysis with rabbit anti-mouse Tid-1 antibody [5],
mouse monoclonal anti-human PARP monoclonal antibody (C2-10;
BD PharMingen), or monoclonal anti-Bcl-XL (H-62; Santa Cruz). Pro-
teins were detected using ECL reagent (Amersham Pharmacia Biotech)
according to the manufacturers protocol.
2.6. Cell growth rate determination
Hoechst 33258 DNA Fluorometric Assay was used to follow the
growth of infected glioma cells over a one-week period. Cells were
seeded in triplicate in 96-well plates at 1.25 · 103 cells/well 16–20 h
prior to infection with control green ﬂuorescent protein (GFP),
hTid-1L- or hTid-S-expressing adenovirus at the appropriate MOI.
Each day thereafter, the wells of one 96-well plate were washed once
with Milli-Q water and frozen at 80C. Following day 7, all plates
were subjected to two cycles of freeze/thawing with 1 h incubation be-
tween with Milli-Q water. Cells were stained with Hoechst 33258 (Sig-
ma; 10 lg/ml in 10 mM Tris, 1 mM EDTA, and 2 M NaCl, pH 7.4)
and ﬂuorescence measurements were made using a CytoFluor Series
4000 plate ﬂuorescence reader. Cell number was calculated from a
standard curve.
2.7. Cell cycle analysis
5 · 105 cells were plated in 60 mm dishes 16–20 h prior to adenoviral
infection. At 72 h following infection, cells were harvested by trypsin-
ization and resuspended at a concentration of 106 cells/ml in PBS. Cells
were incubated for 10 min on ice with propidium iodide (PI) stainingsolution [0.25 mg/ml PI (Sigma), 1% Triton X-100, and 0.1 mg/ml
RNase A (Sigma) in PBS] and DNA content of GFP-positive cells
was then measured using a Coulter Epics XL Flow Center equipped
with the Epics XL System II software for proﬁle analysis.
2.8. Propidium iodide exclusion assay
Cells were seeded at 5 · 105 cells per 60 cm dish and 16–20 h later,
infected with adenovirus expressing GFP alone, hTid-1L or hTid-1S.
Cell viability was assessed 72 h post-infection using the PI exclusion as-
say. Brieﬂy, cells were trypsinized and resuspended in PBS at 106 cells/
ml. Cells were then incubated with PI (PI; 1 mg/ml) for 5 min on ice.
The number of GFP-positive, PI-positive cells was measured using a
FACSVantage SE ﬂow cytometer (Becton Dickinson) equipped with
CELLQuest software for data acquisition.
2.9. Quantitation of apoptosis in SF767 stables
SF767/pBabe and SF767/pBabe-Bcl-XL stable cell lines were plated
in 60 mm dishes at 5 · 105 cells and the next day infected with control
or hTid-1 adenoviruses. At 72 h post-infection, cells were photo-
graphed using a Zeiss ﬂuorescent microscope. The percentage of apop-
totic cells was quantiﬁed by counting the number of cells exhibiting
apoptotic cell morphology from more than 200 GFP positive cells in
ﬁve randomly selected ﬁelds and expressing it as a percentage of total
GFP positive cells.
2.10. Cytochrome c release
Cytosolic fractions were prepared from SF767 parental, SF767/
pBabe and SF767/pBabe-Bcl-XL cells 72 h following infection with
adeno-GFP, - hTid-1L or -hTid-1S as previously described [28]. An ali-
quot (10 lg) was subsequently subjected to Western blot analysis with
anti-cytochrome c antibody (7H8.2C12; BD Pharmingen). The mem-
brane was reprobed with antibodies to actin (I-19; Santa Cruz) as a
loading control.
2.11. Statistical analysis
Statistical analysis of cell growth data was conducted using the f test
to determine whether the data curves for GFP control and wild-type or
mutant hTid-1L and hTid-1S diﬀered signiﬁcantly from those derived
from uninfected cells. An analysis of variance (ANOVA) for a single
factor followed by Duncans multiple range test was also used to deter-
mine if the data for hTid-1L and hTid-1S were signiﬁcantly diﬀerent
from control data in the apoptosis assays. A P value of <0.05 was con-
sidered signiﬁcant in all cases. Bonferonni correction was used to ad-
just for any multiple-testing concerns. Statistical analysis of the data
was performed using Microsoft Excel software.3. Results
3.1. Identiﬁcation of mutant hTid-1 in SF767 glioma
To assess the protein expression levels of hTid-1 isoforms
in human glioma tumors, we screened lysates from glioblas-
toma-derived cell lines by Western blotting with Tid-1 spe-
ciﬁc antibodies. Intriguingly, although none of the ﬁve
glioma cell lines surveyed showed loss of hTid-1 protein,
an aberrant higher molecular weight species of 52 kDa
was observed in the SF767 cell line, in addition to the 43-
kDa hTid-1L and 40-kDa hTid-1S endogenous mature forms
of hTid-1 (Fig. 1A). To determine the nature of the mutation
at the TID1 locus, the presumptive protein-coding region of
the cDNA prepared from SF767 cells was sequenced and
found to contain two additional bases, a thymine at nucleo-
tide position 1438 and cytosine at nucleotide position 1449
(Fig. 1B). These mutations alter the reading frame of the
hTid-1L sequence, introducing an additional 71 amino acids
following the penultimate threonine residue at position 479,
and appear to increase the steady-state abundance of the mu-
tant form of the hTid-1L (hTid-1Lmut) protein. Transient
Fig. 2. Eﬀects of exogenous hTid-1 isoforms on the growth of glioma
cells. (A) U87, (B) U373 and (C) SF767 glioma cells were infected with
adenoviruses expressing GFP alone, hTid-1L, hTid-1S or QPD mutants
of the wild-type proteins. Cell number was determined at the indicated
times using a ﬂuorometric assay. Error bars represent means ± S.D.
between three diﬀerent wells of one representative experiment. Three
independent experiments were performed for each cell line. Statistical
analysis of data shows that curves indicated by asterisk (*) are
signiﬁcantly diﬀerent from uninfected curves in each cell line
(P < 0.005). Exogenous hTid-1L or hTid-1S expression was assessed
over time in infected U87, U373 and SF767 cells by Western blot
analysis of cell lysates with Tid-1 antibodies. The apparent molecular
size of the resulting polypeptides representing cytoplasmic precursors
and mitochondrial processed forms of hTid-1 are indicated in the
margin.
Fig. 1. Identiﬁcation of a hTid-1 mutant in SF767 glioma cell line. (A)
Western blot analysis of hTid-1 expression in human glioblastoma cell
lines. Results from ﬁve cell lines are shown. Cell lysates were
immunoblotted with polyclonal anti-mTid-1 antibodies. Arrows indi-
cate the 43- and 40-kDa isoforms of hTid-1. (B) Sequence analysis of
hTid-1 cDNA prepared from SF767 cells with corresponding
schematic of reading frame change at the C-terminus. Mutations are
underlined in the sequencing chromatogram. (C) Western blot analysis
of cell lysates prepared from COS-1 cells ectopically expressing hTid-
1L mutant variant. An aliquot of SF767 cell lysate (50 lg) was also
subjected to immunoblotting to show comigration with the 52-kDa
aberrant protein indicated by the arrow.
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1 cells revealed that the 551 amino acid precursor protein,
with a predicted molecular mass of 61-kDa, appears to be
correctly processed into a mature 52-kDa form by protease
cleavage of the amino-terminal mitochondrial leader se-
quence (Fig. 1C). Moreover, it conﬁrmed that the dicodon
frameshift mutation generates a protein product that comi-
grates with the aberrant endogenous form observed in
SF767 cells (Fig. 1C).
3.2. hTid-1L and hTid-1S have diﬀerential eﬀects on cell viability
We evaluated the eﬀects of adenovirus-mediated transfer of
hTid-1L and hTid-1S isoforms on growth and survival of gli-
oma cell lines expressing wild-type (U87, U373) or mutant
hTid-1 (SF767). Western blot analysis of cell lysates from gli-
oma cells prepared 24, 48, 72 and 96 h following infection with
Ad-hTid-1L or Ad-hTid-1S showed eﬃcient transduction and
strong expression of 43- and 40-kDa bands corresponding to
the mature processed protein of each isoform, respectively
(Figs. 2A–C). In addition, high levels of 50- and 48-kDa bands
representing the cytoplasmic precursors of each splice variant
were observed. Cell growth was monitored over one week
using a DNA ﬂuorometric assay. No signiﬁcant inhibition of
cell growth was observed in any of the three cell lines over
the 7-day period with expression of GFP alone or hTid-1L with
growth rates comparable to mock-infected cells (Figs. 2A–C).
By contrast, transduction with Ad-hTid-1S resulted in pro-
nounced growth suppression of all three cell lines. A modest
inhibition of growth is observed in U373 following infection
with control virus, indicating a cytotoxic eﬀect of the virus
on the cells.DnaJ protein function is dependent upon a highly conserved
histidine-proline-aspartate (HPD) sequence located within the
J-domain [29]. Mutation of one or all of the amino acids com-
pletely abolishes J-domain-mediated stimulation of Hsp70
ATPase activity. Mutants of the HPD motif in which the his-
tidine has been substituted for glutamine (QPD) were con-
structed to establish that the eﬀects observed on glioma cell
growth by hTid-1 were related to the chaperone function of
the protein. Western blot analysis conﬁrmed high levels of
exogenous expression of the mutant proteins in infected cells
(data not shown). Since these mutations impair ATP hydroly-
sis and consequently, coupling of Hsp70 to hTid-1 and its sub-
strate without aﬀecting the ability of hTid-1 to interact with
the target substrate, they act as dominant-negative forms of
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demonstrated eﬀects on cell growth antithetical to those of
their wild-type counterparts. Speciﬁcally, QPD mutant of the
long isoform, hTid-1L, had pronounced inhibitory eﬀects on
the growth of all three cell lines while in contrast, cells infected
with the QPD mutant of the short isoform, hTid-1S, did not
show any discernible changes in cell viability, with growth
rates comparable to mock- or control-infected cells (Figs.
2A–C).3.3. hTid-1S induces S and G2/M cell cycle arrest
To determine if the growth inhibitory eﬀects observed with
exogenous hTid-1 gene expression in glioma cells was caused
by cell cycle arrest, the DNA proﬁles of infected U87, U373
and SF767 cells were analyzed by ﬂow cytometry. Infection
with control- and hTid-1L-expressing adenovirus had no dis-
cernible eﬀect on the cell cycle proﬁle of the three cell lines
examined at 48 h (data not shown) and 72 h after infection
(Fig. 3A). In marked contrast, adenovirus-mediated transfer
of hTid-1S in SF767 cells induced a pronounced accumulation
of cells in the S and G2/M phases of the cell cycle observed at
48 h (data not shown) and 72 h of infection (Fig. 3A), an event
not observed in wild-type hTid-1-expressing gliomas. Further-
more, a shoulder was also noted in the sub-G1 region at 72 h
post-infection reﬂecting a fraction of SF767 cells with a DNA
content less than that of G1 cells, suggesting that cells infected
with hTid-1S were undergoing cell death.Fig. 3. Eﬀects of exogenous hTid-1L and hTid-1S expression on cell
cycle regulation. (A) Asynchronously growing U87, U373 and SF767
glioma cells were mock-infected or infected with adenoviruses
expressing GFP alone (control), hTid-1L or hTid-1S. At 72 h following
infection, cells were trypsinized and analyzed for DNA content by PI
staining using ﬂow cytometry. Overexpression of hTid-1S induces
apoptosis. (B) Cells were plated at low density and infected with hTid-
1L and hTid-1S expressing adenoviruses. Cell viability was determined
72 h post-infection using the PI exclusion assay. Shown is the relative
cell viability compared with mock-infected control cells. Error bars3.4. Ectopic expression of hTid-1S promotes apoptosis in SF767
gliomas
The apoptosis observed with ﬂow cytometry was quantita-
tively conﬁrmed by the PI exclusion assay. The viability of
SF767 cells infected with hTid-1S declined signiﬁcantly over
time to less than 60% of the viability of adenovirus control-in-
fected cells at 72 h post-infection (Fig. 3B). By contrast, U87
and U373 cells infected with either hTid-1L or hTid-1S or virus
control did not show any apparent changes in cell viability.
These data correlated with apoptotic morphology character-
ized by chromatin condensation and formation of apoptotic
bodies detected with DAPI staining of ﬂoating hTid-1S-in-
fected SF767 cells (data not shown).
indicate the range between two independent experiments. Asterisk (*)
indicates the data that were found to be signiﬁcantly diﬀerent from
control data (P < 0.003).3.5. hTid-1S induces caspase activation and cytochrome c release
from mitochondria
To understand how hTid-1S triggers cell death in SF767
cells, we ﬁrst examined whether caspases, the major mediators
of classical apoptosis pathways, are activated in response to
hTid-1S overexpression. To this end, we assayed for the cleav-
age of the caspase substrate Poly-(ADP-ribose) polymerase
(PARP) in cell lysates prepared from hTid-1S-infected SF767
cells at 24, 48, 72 and 96 h post-infection (Fig. 4A). As
controls, parallel cultures were infected with adenoviruses
expressing either GFP or hTid-1L. Western blot analysis with
anti-PARP antibody shows that intact PARP migrates at
116 kDa in control adeno-GFP-infected cells, whereas in cells
overxexpressing hTid-1S there is cleavage of PARP to an 89-
kDa fragment (Fig. 4A, top panel) observed at 48 h post-infec-
tion, demonstrating that hTid-1S is suﬃcient in activating one
or more caspases in these cells. By contrast, caspase activation
was not detectable in cells expressing exogenous hTid-1L.
Intriguingly, hTid-1S-triggered caspase activation in SF767cells coincided with proteolytic cleavage of the 52-kDa hTid-
1L mutant (Fig. 4A, lower panel).
Another feature of apoptosis is the collapse of mitochondrial
membrane integrity and release of mitochondrial constituents
such as cytochrome c (cyto-C), which potentiates the formation
of the apoptosome and activation of eﬀector caspases [30]. To
determine whether the apoptotic activity of hTid-1S is associ-
ated with release of cyto-C, cytosolic fractions were prepared
from parental SF767 cells following infection with control-
GFP, hTid-1L- and hTid-1S-expressing adenovirus and the ex-
tent of cyto-C release was assessed by Western blotting with
an anti-cyto-C antibody (Fig. 4B). Whereas low to undetectable
levels of cyto-C were observed in control and hTid-1L-infected
cells, hTid-1S expression in SF767 cells elicited the release of
cyto-C from the mitochondria (Fig. 4B, lanes 1–3). Probing cell
Fig. 4. hTid-1S induces caspase activation and cytochrome c release in SF767 gliomas. (A) Cell lysates were prepared at the indicated time points
following infection with adenovirus and subjected to immunoblot analysis with anti-PARP antibody (upper panel) or with anti-Tid-1 antibodies
(lower panel). (B) Analysis of cytochrome c release in control, hTid-1L- and hTid-1S-infected SF767/parental, SF767/pBabe and SF767/pBabe-Bcl-XL
cells at 72 h post-infection. Cytosolic fractions (10 lg) were analyzed by Western blotting using anti-cytochrome C antibody. The membrane was
reprobed with antibodies to actin as loading control. Lysates were also immunoblotted for levels of hTid-1 proteins (right panel). (C) Bcl-XL
suppresses apoptosis induced by hTid-1S. Percentage of apoptotic cells in hTid-1L- or hTid-1S-infected SF767/pBabe and SF767/Bcl-XL stable lines at
72 h post-infection is shown. Error bars represent means ± S.D. between three independent experiments performed in triplicate. Asterisk (*) indicates
the data that were found to be signiﬁcantly diﬀerent from control data (P < 0.01). Inset, Western blot analysis of cell lysates prepared from SF767
cells infected with either empty pBabe or pBabe/Bcl-XL retrovirus using antibodies to Bcl-XL, depicting protein levels of exogenous Bcl-XL.
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expression levels of exogenous hTid-1L and hTid-1S.
3.6. Bcl-XL protects cells from hTid-1S-induced cell death and
cytochrome c release
It is well established that the expression of either Bcl-2 or
Bcl-XL is known to maintain the integrity of mitochondria
and to prevent cyto-C release in response to diverse apoptotic
stimuli [31]. To determine if cyto-C release mediated by over-
expression of hTid-1S in SF767 is inhibited by Bcl-XL, SF767
cells stably expressing Bcl-XL were generated by retroviral
infection with pBabe-Bcl-XL. The level of overexpression of
Bcl-XL in the stable cell lines was examined by Western blot-
ting analysis (Fig. 4C, inset). Cytosolic fractions were preparedfrom SF767/pBabe-Bcl-XL and SF767/pBabe control cells 72 h
after infection with control, hTid-1L- and hTid-1S-expressing
adenovirus and the extent of cyto-C release was assessed by
immunoblot analysis. As shown in Fig. 4B, cyto-C was de-
tected in the cytosolic fraction of SF767/pBabe cells following
infection with hTid-1S but not with hTid-1L and the hTid-1S-
induced release of cyto-C from the mitochondria was com-
pletely suppressed in SF767 cells overexpressing Bcl-XL.
To assess whether Bcl-XL can block apoptosis triggered by
hTid-1S, SF767/pBabe, SF767/pBabe-Bcl-XL cells were then
infected with adenovirus expressing GFP, hTid-1L or hTid-1S
and apoptosis was visualized and quantiﬁed at 72 h post-infec-
tion by photomicrography (Fig. 4C), as well as trypan blue
exclusion (data not shown). Overexpression of pBabe/Bcl-XL
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imposed by hTid-1S on SF767 cells. The extent of cell death
inhibition by Bcl-XL was quantitated and determined to be
greater than 50% (Fig. 4C). Taken together, our ﬁndings sug-
gest that hTid-1S regulates apoptotic signaling in SF767 at a
convergence point at the mitochondria that targets cyto-C re-
lease and is inhibitable by Bcl-XL.4. Discussion
Molecular chaperones have emerged as important determi-
nants of cell growth and survival responses and the relative
abundance of these proteins can have profound eﬀects on cell
transformation processes. Hsp70 and other heat shock pro-
teins have been shown to eﬀectively inhibit both caspase-
dependent and caspase-independent apoptotic stimuli and con-
fer immortality in various human cell types [18,32,33]. Consis-
tent with these observations, pathological overexpression of
Hsp70 and Hsp90 has been reported in breast tumors, lung
cancer and leukemias and is associated with refractory disease
and poor prognosis [34], whereas antisense depletion results in
the induction of apoptosis in several human tumors [35,36]
providing proof of concept evidence that elevated expression
of chaperone proteins is important for maintaining tumor cell
survival.
This is the ﬁrst study to identify a coding region sequence
mutation targeting a member of the chaperone family. We
found one glioma cell line, SF767, with a heterozygous TID1
frameshift mutation which yields aberrantly high levels of a
52-kDa hTid-1L mutant variant, although the functional sig-
niﬁcance of this alteration in relation to the tumorigenic phe-
notype of SF767 gliomas is presently unknown. One
possibility is that tumor-associated mutant forms of hTid-1
could function with other genetic alterations in exerting an
anti-apoptotic gain of function activity, which may contribute
to survival and progression of malignant gliomas harboring
such mutations.
We have demonstrated that the two major splice variants of
hTid-1 diﬀerentially aﬀect glioma cell growth and viability in
vitro. While adenoviral transduction of the long isoform,
hTid-1L, had no discernible eﬀect on the growth properties
of glioma cells, we observed marked inhibition of cell prolifer-
ation with overexpression of the hTid-1S splice variant in all
glioma cell lines tested (Fig. 2 and data not shown). This obser-
vation together with the ﬁnding that the transdominant inhib-
itory QPD mutant of hTid-1L, which presumably antagonizes
endogenous hTid-1L function, is seen to inhibit tumor cell
growth suggests a role for hTid-1S in growth suppression
and conversely, hTid-1L in promoting the growth and survival
of gliomas.
We have found that ectopic expression of hTid-1S in SF767
glioma cells harboring a mutant TID1 allele rendered these
cells susceptible to apoptosis, while causing growth arrest in
wild-type hTid-1-expressing U373 and U87 cells. Along a sim-
ilar vein, there are reports correlating induction of apoptosis
with gene transfer of the p53 tumor suppressor in mutant-
p53 but not wild-type p53 glioma cell lines [38,39]. It is note-
worthy that in SF767 cells, induction of apoptosis at 72 h by
exogenous hTid-1S coincides with caspase activation and pro-
teolytic cleavage of the hTid-1L mutant species. This has led usto speculate that the overabundance of this hTid-1L mutant
could result in novel substrate combinations with Hsps, which
may contribute to development of the transformed phenotype
by altering the activity, localization or stability of key regula-
tory substrates that enhance cellular resistance to apoptosis in
these tumor cells. In keeping with this idea, caspase cleavage of
the hTid-1L mutant in SF767 cells may activate the tumor-
associated death pathway silenced by this mutant or alterna-
tively convert hTid-1L mutant from an inhibitor of apoptosis
to an activator of cell death, a paradigm that has been ascribed
to other caspase substrates such as Bcl-2, RIP and Livin [40–
42].
Our results describing the pro-apoptotic properties of hTid-
1S in SF767 gliomas appear at variance with those published
by Syken et al. [4], in which inducible expression of recombi-
nant hTid-1S in O2OS osteosarcoma cell lines decreased sus-
ceptibility to damaging stimuli such as TNFa [4]. By
contrast, we have observed a modest enhancement of etopo-
side cytotoxicity by hTid-1S in gliomas, however, only at short
exposure times (data not shown). The lack of consistency in
the roles of hTid-1 proteins in the regulation of cell growth
and apoptosis raises the possibility that the ability of hTid-1
splice variants to inﬂuence chemosensitization might vary
depending upon the chemotherapeutic agent and schedule em-
ployed or may reﬂect cell-type dependent diﬀerences. However,
a recent report by the same group [37] revealed that RNAi
depletion of both hTid-1L and hTid-1S, but not that of hTid-1L
alone, rendered tumor cells completely refractile to apoptotic
stimuli supporting our contention that hTid-1S is endowed
with pro-apoptotic properties.
Results from PARP cleavage and subcellular fractionation
experiments in SF767 cells revealed that hTid-1S expression
is suﬃcient for release of cyto-C and eﬀector caspase activa-
tion. Moreover, our observation that Bcl-XL can protect cells
from hTid-1S-induced cell death suggests that hTid-1S action
converges at the mitochondria. The mechanism by which
Tid-1 proteins engage the intrinsic pathway remains unclear,
however, as Tid-1 proteins reside predominantly in the mito-
chondria, one possibility is that they are involved in direct reg-
ulation of mitochondrial membrane permeability (MMP) by
targeting components of the permeability transition (PT) pore
implicated in cyto-C release [43]. For example, it will be inter-
esting to determine whether hTid-1S modulates the interaction
between the mitochondrial voltage-dependent anion channel,
VDAC2 and the inactive conformer of pro-apoptotic Bak, en-
abling homodimerization and activation of Bak, which has
been shown to induce eﬄux of cyto-C by accelerating the PT
pore opening of VDAC2 [44]. Alternatively, hTid-1 might inte-
grate death signals by impinging on signaling cascades that lie
upstream of the mitochondria. Tid-1 proteins have recently
been reported to modulate NF-jB signaling, in association
with Hsp70, by repressing the activity of IjB kinase b (IKKb)
thus interfering with IjBa phosphorylation and degradation
and release of NF-jB transcription factor for nuclear translo-
cation [45]. NF-jB is a potent modulator of apoptosis as it in-
duces the expression of a number of genes whose products can
inhibit apoptosis induced by both death receptors and mito-
chondria-dependent pathways [46].
In summary, we have shown that hTid-1S is capable of initi-
ating apoptotic cell death in gliomas that express mutated but
not wildtype endogenous hTid-1 proteins. Future studies will
have to be directed towards identifying the cellular targets of
G.A. Trentin et al. / FEBS Letters 578 (2004) 323–330 329hTid-1 isoforms in order to elucidate the molecular
mechanisms by which hTid-1 proteins engage the cell death
machinery.
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